Differential localization of MTI-MMP in human prostate cancer tissue: Role of IGF-IR in MTI-MMP expression

Isis C Sroka, Kathy McDaniel, Raymond B Nagle, G. Tim Bowden

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

BACKGROUND. MT1-MMP is a metalloproteinase involved in prostate cancer metastasis. The IGF-1R is a tyrosine kinase receptor involved with tumor progression and metastasis. The purpose of this investigation was to examine MT1-MMP and IGF-1R expression and localization in prostate cancer tissues and explore the role of IGF-1R in regulating MT1-MMP in prostate cancer cell lines. METHODS. Immunohistochemistry was utilized to study MT1-MMP and IGF-1R expression in human prostate tissues. IGF-1R regulation of MT1-MMP expression was determined by gene promoter analysis, quantitative RT-PCR and Western blot analysis following pharmacological inhibition of the receptor in PC-3N cells and treatment of LNCaP cells with androgen and IGF-1. RESULTS. MT1-MMP expression was high in the apical regions of the luminal cells in PIN and prostate cancer and less intense in the basalateral regions of benign tissues. IGF-1R was expressed primarily in the basal cells of normal glands and highly expressed in prostate cancer. Inhibition of IGF-1R in PC-3N cells decreased MT1-MMP expression and treatment of LNCaP cells with a synthetic androgen and IGF-1 increased MT1-MMP expression. CONCLUSIONS. These data demonstrate that MT1-MMP is highly expressed in the apical cytoplasmic regions of the luminal cells in PIN and prostate cancer when compared to basalateral cytoplasmic membrane staining in benign glands. Additionally, we demonstrate that IGF-1R is highly expressed in human prostate carcinoma. These findings suggest that MT1-MMP localization and IGF-1R expression in prostate carcinoma could be predictive biomarkers for aggressive disease and support IGF-1R as a promising therapeutic target to decrease processes of prostate cancer metastasis.

Original languageEnglish (US)
Pages (from-to)463-476
Number of pages14
JournalProstate
Volume68
Issue number5
DOIs
StatePublished - Apr 1 2008

Fingerprint

Matrix Metalloproteinase 14
Matrix Metalloproteinases
Prostatic Neoplasms
Prostate
Neoplasm Metastasis
Insulin-Like Growth Factor I
Testosterone Congeners
Carcinoma
Receptor Protein-Tyrosine Kinases
Metalloproteases
Androgens
Therapeutics
Biomarkers
Western Blotting
Immunohistochemistry
Cell Membrane
Pharmacology
Staining and Labeling

Keywords

  • IGF-1R
  • MT1-MMP
  • Prostate

ASJC Scopus subject areas

  • Urology

Cite this

Differential localization of MTI-MMP in human prostate cancer tissue : Role of IGF-IR in MTI-MMP expression. / Sroka, Isis C; McDaniel, Kathy; Nagle, Raymond B; Bowden, G. Tim.

In: Prostate, Vol. 68, No. 5, 01.04.2008, p. 463-476.

Research output: Contribution to journalArticle

@article{3f32bedbe4084fd4bff7be756fed17f0,
title = "Differential localization of MTI-MMP in human prostate cancer tissue: Role of IGF-IR in MTI-MMP expression",
abstract = "BACKGROUND. MT1-MMP is a metalloproteinase involved in prostate cancer metastasis. The IGF-1R is a tyrosine kinase receptor involved with tumor progression and metastasis. The purpose of this investigation was to examine MT1-MMP and IGF-1R expression and localization in prostate cancer tissues and explore the role of IGF-1R in regulating MT1-MMP in prostate cancer cell lines. METHODS. Immunohistochemistry was utilized to study MT1-MMP and IGF-1R expression in human prostate tissues. IGF-1R regulation of MT1-MMP expression was determined by gene promoter analysis, quantitative RT-PCR and Western blot analysis following pharmacological inhibition of the receptor in PC-3N cells and treatment of LNCaP cells with androgen and IGF-1. RESULTS. MT1-MMP expression was high in the apical regions of the luminal cells in PIN and prostate cancer and less intense in the basalateral regions of benign tissues. IGF-1R was expressed primarily in the basal cells of normal glands and highly expressed in prostate cancer. Inhibition of IGF-1R in PC-3N cells decreased MT1-MMP expression and treatment of LNCaP cells with a synthetic androgen and IGF-1 increased MT1-MMP expression. CONCLUSIONS. These data demonstrate that MT1-MMP is highly expressed in the apical cytoplasmic regions of the luminal cells in PIN and prostate cancer when compared to basalateral cytoplasmic membrane staining in benign glands. Additionally, we demonstrate that IGF-1R is highly expressed in human prostate carcinoma. These findings suggest that MT1-MMP localization and IGF-1R expression in prostate carcinoma could be predictive biomarkers for aggressive disease and support IGF-1R as a promising therapeutic target to decrease processes of prostate cancer metastasis.",
keywords = "IGF-1R, MT1-MMP, Prostate",
author = "Sroka, {Isis C} and Kathy McDaniel and Nagle, {Raymond B} and Bowden, {G. Tim}",
year = "2008",
month = "4",
day = "1",
doi = "10.1002/pros.20718",
language = "English (US)",
volume = "68",
pages = "463--476",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Differential localization of MTI-MMP in human prostate cancer tissue

T2 - Role of IGF-IR in MTI-MMP expression

AU - Sroka, Isis C

AU - McDaniel, Kathy

AU - Nagle, Raymond B

AU - Bowden, G. Tim

PY - 2008/4/1

Y1 - 2008/4/1

N2 - BACKGROUND. MT1-MMP is a metalloproteinase involved in prostate cancer metastasis. The IGF-1R is a tyrosine kinase receptor involved with tumor progression and metastasis. The purpose of this investigation was to examine MT1-MMP and IGF-1R expression and localization in prostate cancer tissues and explore the role of IGF-1R in regulating MT1-MMP in prostate cancer cell lines. METHODS. Immunohistochemistry was utilized to study MT1-MMP and IGF-1R expression in human prostate tissues. IGF-1R regulation of MT1-MMP expression was determined by gene promoter analysis, quantitative RT-PCR and Western blot analysis following pharmacological inhibition of the receptor in PC-3N cells and treatment of LNCaP cells with androgen and IGF-1. RESULTS. MT1-MMP expression was high in the apical regions of the luminal cells in PIN and prostate cancer and less intense in the basalateral regions of benign tissues. IGF-1R was expressed primarily in the basal cells of normal glands and highly expressed in prostate cancer. Inhibition of IGF-1R in PC-3N cells decreased MT1-MMP expression and treatment of LNCaP cells with a synthetic androgen and IGF-1 increased MT1-MMP expression. CONCLUSIONS. These data demonstrate that MT1-MMP is highly expressed in the apical cytoplasmic regions of the luminal cells in PIN and prostate cancer when compared to basalateral cytoplasmic membrane staining in benign glands. Additionally, we demonstrate that IGF-1R is highly expressed in human prostate carcinoma. These findings suggest that MT1-MMP localization and IGF-1R expression in prostate carcinoma could be predictive biomarkers for aggressive disease and support IGF-1R as a promising therapeutic target to decrease processes of prostate cancer metastasis.

AB - BACKGROUND. MT1-MMP is a metalloproteinase involved in prostate cancer metastasis. The IGF-1R is a tyrosine kinase receptor involved with tumor progression and metastasis. The purpose of this investigation was to examine MT1-MMP and IGF-1R expression and localization in prostate cancer tissues and explore the role of IGF-1R in regulating MT1-MMP in prostate cancer cell lines. METHODS. Immunohistochemistry was utilized to study MT1-MMP and IGF-1R expression in human prostate tissues. IGF-1R regulation of MT1-MMP expression was determined by gene promoter analysis, quantitative RT-PCR and Western blot analysis following pharmacological inhibition of the receptor in PC-3N cells and treatment of LNCaP cells with androgen and IGF-1. RESULTS. MT1-MMP expression was high in the apical regions of the luminal cells in PIN and prostate cancer and less intense in the basalateral regions of benign tissues. IGF-1R was expressed primarily in the basal cells of normal glands and highly expressed in prostate cancer. Inhibition of IGF-1R in PC-3N cells decreased MT1-MMP expression and treatment of LNCaP cells with a synthetic androgen and IGF-1 increased MT1-MMP expression. CONCLUSIONS. These data demonstrate that MT1-MMP is highly expressed in the apical cytoplasmic regions of the luminal cells in PIN and prostate cancer when compared to basalateral cytoplasmic membrane staining in benign glands. Additionally, we demonstrate that IGF-1R is highly expressed in human prostate carcinoma. These findings suggest that MT1-MMP localization and IGF-1R expression in prostate carcinoma could be predictive biomarkers for aggressive disease and support IGF-1R as a promising therapeutic target to decrease processes of prostate cancer metastasis.

KW - IGF-1R

KW - MT1-MMP

KW - Prostate

UR - http://www.scopus.com/inward/record.url?scp=41849116032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41849116032&partnerID=8YFLogxK

U2 - 10.1002/pros.20718

DO - 10.1002/pros.20718

M3 - Article

C2 - 18196535

AN - SCOPUS:41849116032

VL - 68

SP - 463

EP - 476

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 5

ER -